Related Experiment Videos
[Functional interaction between estrogen receptor and proto-oncogene products c-Jun and c-Fos]
Abstract:
We show here that TPA treatment of MCF-7 cells represses estrogen receptor dependent transcriptional activity, while increasing the AP1 binding activity. These two events are probably linked, since the transcriptional activity of the estrogen receptor in these cells is repressed by overexpression of both cJun or cFos, the components of the AP1 transcripts factor. On the contrary no repression was observed after overexpression of another member of the jun family, the JunD. The repression caused by cJun or cFos may depend on partially different pathways. Our results suggest that the inhibition of TPA of the estrogen dependent growth of the MCF-7 cells is caused by over expression of cJun and cFos.
Insights
TPA treatment represses estrogen receptor activity and boosts AP1 binding in MCF-7 cells. This inhibition of estrogen-dependent growth is linked to the overexpression of cJun and cFos proteins.
Area of Science:
- Molecular biology
- Cell signaling
- Cancer research
Context:
- MCF-7 cells are a human breast cancer cell line commonly used in research.
- Estrogen receptor (ER) signaling plays a crucial role in the growth of many breast cancers.
- AP1 (activator protein 1) is a transcription factor involved in cell proliferation and differentiation.
Purpose:
- To investigate the molecular mechanisms by which TPA (12-O-tetradecanoylphorbol-13-acetate) affects ER transcriptional activity and AP1 binding in MCF-7 cells.
- To determine the role of cJun, cFos, and JunD in mediating the effects of TPA on ER activity and cell growth.
Summary:
- TPA treatment of MCF-7 cells leads to decreased ER-dependent transcriptional activity and increased AP1 binding activity.
- Overexpression of cJun or cFos, components of the AP1 transcription factor, represses ER transcriptional activity.
- JunD overexpression did not result in ER repression, suggesting pathway specificity.
- The findings suggest that TPA's inhibition of estrogen-dependent MCF-7 cell growth is mediated by the overexpression of cJun and cFos.
Impact:
- Provides insights into the cross-talk between ER and AP1 signaling pathways in breast cancer cells.
- Identifies potential therapeutic targets for managing estrogen-dependent breast cancers.
- Contributes to understanding the complex regulatory mechanisms governing cell growth and gene expression.